Wednesday, Jan 17, 2024 · SEC filings

What the smart money revealed on Jan 17

Real insider buys15insiders · $1.62M
Real insider sales62insiders · $47.1M
Fund 13Fs filed—not loaded for this day
Activist 13Ds filed—not loaded for this day

640 insider filings came in. We hid 79 planned (10b5-1) sellers and 462 people whose filings were routine, like grants and tax withholding.

group

3 insiders at Marpai (MRAI) bought $1.22M of stock

Roles: CEO, Director. Several insiders buying in the same few days is rare.

Cluster buy Form 4 Traded Jan 16
$1.22M
trending_up

Opko Health (OPK) Vice Chairman and CTO Jane Hsiao bought $142K

150,000 shares on the open market. Not a grant or an option exercise.

Real buy Form 4 Traded Jan 17
$142K
trending_up

NB Bancorp (NBBK) Director Paul Ayoub bought $140K

10,070 shares on the open market. Not a grant or an option exercise.

Real buy Form 4 Traded Jan 11
$140K
trending_up

Worthington Steel (WS) Director Charles Chiappone bought $51.9K

1,850 shares on the open market. Not a grant or an option exercise.

Real buy Form 4 Traded Jan 12
$51.9K
trending_down

AutoZone (AZO) Sr. Vice President Domingo Hurtado sold $14.2M

Not marked as a planned 10b5-1 sale. Most of the shares sold came from stock options they exercised the same day. Still holds 156 shares directly.

Real sale Form 4 Traded Jan 16
$14.2M
trending_down

CrowdStrike (CRWD) President Michael Sentonas sold $6.33M

Not marked as a planned 10b5-1 sale. Sold 7% of the shares they held directly. Still holds 311,872 shares.

Real sale Form 4 Traded Jan 16
$6.33M
trending_down

Bank of New York Mellon (BNY) Sr. Exec. Vice President Catherine Keating sold $1.72M

Not marked as a planned 10b5-1 sale. Sold 25% of the shares they held directly. Still holds 95,714 shares.

Real sale Form 4 Sold 25% of stake Traded Jan 16
$1.72M
Show 9 more real buys
Show 59 more real sales
DXCM Dexcom · President Kevin Sayer · Traded Jan 16
$4.61M
AZO AutoZone · Sr. Vice President Dennis LeRiche · Traded Jan 16
$4.52M
TEAM Atlassian · Co-CEO Michael Cannon-Brookes · Traded Jan 16
$1.98M
TEAM Atlassian · Co-CEO Scott Farquhar · Traded Jan 16
$1.98M
AZO AutoZone · Sr. Vice President Grant McGee · Traded Jan 16
$1.84M
KRUS Kura Sushi USA · Officer Brent Takao · Traded Jan 12
$1.28M
BNY Bank of New York Mellon · Sr. Exec. Vice President Hanneke Smits · Traded Jan 16
$851K
MSM MSC Industrial Direct · President and CEO Erik Gershwind · Traded Jan 16
$720K
SNX TD SYNNEX · Head of Hyve Solutions Dennis Polk · Traded Jan 16
$696K
REPX Riley Exploration Permian · Director Bryan Lawrence · Traded Jan 12–17
$581K
APLS Apellis Pharmaceuticals · CEO Cedric Francois · Traded Jan 16
$525K
DXCM Dexcom · EVP COO Jacob Leach · Traded Jan 16
$492K
MORF Morphic Holding · CEO Praveen Tipirneni · Traded Jan 16
$383K
DDS Dillard's · Director J Watts Jr. · Traded Jan 17
$383K
PLAY Dave & Buster's Entertainment · SVP John Mulleady · Traded Jan 16
$362K
DXCM Dexcom · EVP Chief Human Resources Sadie Stern · Traded Jan 16
$359K
DXCM Dexcom · EVP CFO Jereme Sylvain · Traded Jan 16
$338K
OM Outset Medical · SVP Operations and R&D Marc Nash · Traded Jan 16
$291K
APLS Apellis Pharmaceuticals · General Counsel David Watson · Traded Jan 16
$283K
LEGH Legacy Housing · Director Curtis Hodgson · Traded Jan 16
$174K
MORF Morphic Holding · President Bruce Rogers · Traded Jan 16
$174K
MORF Morphic Holding · CFO and COO Marc Schegerin · Traded Jan 16
$166K
APLS Apellis Pharmaceuticals · CFO Timothy Sullivan · Traded Jan 16
$149K
APLS Apellis Pharmaceuticals · Chief Commercial Officer Adam Townsend · Traded Jan 16
$149K
MORF Morphic Holding · SVP Finance and CAO Robert Farrell Jr. · Traded Jan 16
$140K
APLS Apellis Pharmaceuticals · Chief Technical Officer Nur Nicholson · Traded Jan 16
$124K
MORF Morphic Holding · General Counsel and Secretary William DeVaul · Traded Jan 16
$124K
JOBY Joby Aviation · Head of Product Eric Allison · Traded Jan 16
$119K
APLS Apellis Pharmaceuticals · Chief Scientific Officer Pascal Deschatelets · Traded Jan 16
$109K
APLS Apellis Pharmaceuticals · Chief People Officer Karen Lewis · Traded Jan 16
$109K
APLS Apellis Pharmaceuticals · Chief Business and Strat Officer Mark DeLong · Traded Jan 16
$109K
ODC Oil-Dri Corp of America · Vice President of Operations Aaron Christiansen · Traded Jan 16
$71K
PI Impinj · CEO Chris Diorio · Traded Jan 16
$69.4K
APLS Apellis Pharmaceuticals · VP/Chief Accounting Officer James Chopas · Traded Jan 16
$57.7K
BRZE Braze · Chief Accounting Officer Pankaj Malik · Traded Jan 12
$53.7K
BE Bloom Energy · EVP Guillermo Brooks · Traded Jan 16
$39.7K
JOBY Joby Aviation · General Counsel and Corporate Secretary Kate DeHoff · Traded Jan 16
$35.1K
OM Outset Medical · Chair and CEO Leslie Trigg · Traded Jan 16
$34.9K
PI Impinj · Chief Revenue Officer Jeffrey Dossett · Traded Jan 16
$30.1K
APLS Apellis Pharmaceuticals · Chief Development Officer Jeffrey Eisele · Traded Jan 16
$29.3K
EGHT 8x8 · Chief Accounting Officer Suzy Seandel · Traded Jan 16
$29.1K
ADAPY Adaptimmune Therapeutics · CEO Adrian Rawcliffe · Traded Jan 16–17
$27.5K
PI Impinj · COO Hussein Mecklai · Traded Jan 16
$26.4K
VRSN Verisign · EVP- Engineering Danny McPherson · Traded Jan 16
$25.4K
PI Impinj · CFO Cary Baker · Traded Jan 16
$22.6K
BE Bloom Energy · EVP Shawn Soderberg · Traded Jan 16
$21.5K
TOST Toast · Principal Accounting Officer James Matlock · Traded Jan 16
$18.4K
ADAPY Adaptimmune Therapeutics · COO William Bertrand Jr. · Traded Jan 16–17
$16.4K
ADAPY Adaptimmune Therapeutics · Chief Medical Officer Elliot Norry · Traded Jan 16–17
$14.1K
ADAPY Adaptimmune Therapeutics · Chief Patient Supply Officer John Lunger · Traded Jan 17
$12.1K
OM Outset Medical · CFO Nabeel Ahmed · Traded Jan 16
$7.4K
OM Outset Medical · General Counsel John Brottem · Traded Jan 16
$6.35K
OM Outset Medical · Chief Commercial Officer Steven Williamson · Traded Jan 16
$4.27K
OM Outset Medical · Chief People Officer Stacey Porter · Traded Jan 16
$3.29K
AEHR Aehr Test Systems · CTO Donald Richmond II · Traded Jan 16
$3.1K
OM Outset Medical · CTO Jean-Olivier Racine · Traded Jan 16
$3.1K
VIRC Virco MFG · Vice President Patricia Quinones · Traded Jan 16
$1.22K
GRDX First Wave BioPharma · Chairman James Sapirstein · Traded Jan 12
$697
GRDX First Wave BioPharma · CFO Sarah Romano · Traded Jan 12
$412

13F season

Holdings as of Dec 31, 2023 are due Feb 14

49 funds have filed so far. 40 filed for the quarter before.

Biggest real insider buys, Jan 11–17

Open-market buys by officers and directors, filed in the 7 days up to Jan 17.

Where this data comes from. Insider trades, fund holdings, activist stakes and company results come from public SEC EDGAR filings (Forms 4, 13F, 13D/13G, 10-Q and 8-K). Congress trades come from the STOCK Act reports members file with the House Clerk and the Senate. Daily closing prices come from post-no-preference/stocks on DoltHub, a community-run database shared under CC BY-SA 4.0; the prices we show stay under that license. They are each day's close, not live or official exchange prices.

This is data, not investment advice. About StockToast · Your watchlist